A lentiviral vector B cell gene therapy platform for the delivery of the anti-HIV-1 eCD4-Ig-knob-in-hole-reversed immunoadhesin is a research paper published in Molecular Therapy β Methods & Clinical Development (2023). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: F30HL137563
National Institute of Allergy and Infectious Diseases
Grant: U54AI150472
NIDDK NIH HHS
Grant: U54 DK106829
NIAID NIH HHS
Grant: R01 AI152523
NIAID NIH HHS
Grant: R56 AI143563
NIAID NIH HHS
Grant: R01 AI143563
NICHD NIH HHS
Grant: T32 HD101442
National Institutes of Health
Grant: 1R01AI152523-01
Expediting elicitation of HIV-1 bnAbs with membrane Env vaccines
National Institutes of Health
Grant: 7U54AI150472-10
HIV Interactions In Viral Evolution
National Institutes of Health
Grant: 5F30HL137563-02
In vivo gene editing of CCR5 in bone marrow using improved lentiviral vectors
National Institutes of Health
Grant: 1R01AI143563-01A1
HIV-1 vaccine design emphasizing bnAb targets on membrane Env liposomes
Bill and Melinda Gates Foundation
National Institutes of Health
Fields of Study
Keywords